News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,607 Results
Type
Article (39911)
Company Profile (271)
Press Release (658425)
Section
Business (205014)
Career Advice (2020)
Deals (35525)
Drug Delivery (96)
Drug Development (81197)
Employer Resources (172)
FDA (16179)
Job Trends (14898)
News (346295)
Policy (32606)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2564)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49707)
ALS (81)
Alzheimer's disease (1351)
Antibody-drug conjugate (ADC) (110)
Approvals (16180)
Artificial intelligence (225)
Autoimmune disease (14)
Automation (14)
Bankruptcy (362)
Best Places to Work (11658)
BIOSECURE Act (19)
Biosimilars (101)
Biotechnology (190)
Bladder cancer (57)
Brain cancer (24)
Breast cancer (246)
Cancer (1962)
Cardiovascular disease (147)
Career advice (1685)
Career pathing (29)
CAR-T (140)
Cell therapy (394)
Cervical cancer (17)
Clinical research (65769)
Collaboration (764)
Compensation (446)
Complete response letters (18)
COVID-19 (2596)
CRISPR (35)
C-suite (204)
Cystic fibrosis (98)
Data (1897)
Decentralized trials (2)
Denatured (18)
Depression (36)
Diabetes (242)
Diagnostics (6347)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (109)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (84)
Earnings (86248)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (112075)
Executive appointments (631)
FDA (17267)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (96)
Generative AI (18)
Gene therapy (270)
GLP-1 (681)
Government (4391)
Grass and pollen (4)
Guidances (48)
Healthcare (18822)
Huntington's disease (23)
IgA nephropathy (21)
Immunology and inflammation (104)
Indications (26)
Infectious disease (2725)
Inflammatory bowel disease (135)
Inflation Reduction Act (10)
Influenza (46)
Intellectual property (83)
Interviews (311)
IPO (16517)
IRA (42)
Job creations (3663)
Job search strategy (1434)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7934)
Liver cancer (70)
Lung cancer (287)
Lymphoma (129)
Machine learning (2)
Management (58)
Manufacturing (265)
MASH (59)
Medical device (13323)
Medtech (13328)
Mergers & acquisitions (19470)
Metabolic disorders (621)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1814)
NextGen: Class of 2025 (6547)
Non-profit (4487)
Northern California (2388)
Now hiring (37)
Obesity (336)
Opinion (205)
Ovarian cancer (71)
Pain (76)
Pancreatic cancer (77)
Parkinson's disease (130)
Partnered (18)
Patents (199)
Patient recruitment (93)
Peanut (46)
People (57374)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20502)
Phase II (28971)
Phase III (21573)
Pipeline (959)
Podcasts (47)
Policy (110)
Postmarket research (2564)
Preclinical (8680)
Press Release (64)
Prostate cancer (91)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (350)
Real estate (5946)
Recruiting (65)
Regulatory (22175)
Reports (46)
Research institute (2323)
Resumes & cover letters (350)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (122)
Series B (77)
Service/supplier (13)
Sickle cell disease (49)
Southern California (2068)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3624)
State (2)
Stomach cancer (12)
Supply chain (59)
The Weekly (26)
United States (20891)
Vaccines (654)
Venture capitalists (38)
Webinars (12)
Weight loss (225)
Women's health (33)
Worklife (15)
Date
Today (21)
Last 7 days (565)
Last 30 days (2534)
Last 365 days (33584)
2025 (7649)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55834)
2020 (54153)
2019 (46641)
2018 (35123)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (720)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37891)
Australia (6208)
California (5457)
Canada (1854)
China (466)
Colorado (245)
Connecticut (256)
Delaware (123)
Europe (81293)
Florida (809)
Georgia (190)
Idaho (58)
Illinois (491)
India (24)
Indiana (289)
Iowa (9)
Japan (138)
Kansas (101)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (823)
Massachusetts (4099)
Michigan (208)
Minnesota (366)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (63)
New Jersey (1547)
New Mexico (28)
New York (1561)
North Carolina (909)
North Dakota (7)
Northern California (2388)
Ohio (192)
Oklahoma (14)
Oregon (34)
Pennsylvania (1239)
Puerto Rico (9)
Rhode Island (26)
South America (1097)
South Carolina (18)
South Dakota (1)
Southern California (2068)
Tennessee (92)
Texas (814)
Utah (163)
Virginia (128)
Washington D.C. (58)
Washington State (507)
West Virginia (3)
Wisconsin (48)
698,607 Results for "ensysce biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ensysce Biosciences to Participate in the 37th Annual ROTH Conference
March 5, 2025
·
1 min read
Press Releases
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results
March 10, 2025
·
11 min read
Press Releases
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain
March 19, 2025
·
2 min read
Press Releases
Ensysce Biosciences Issues Annual Shareholder Letter
January 9, 2025
·
12 min read
Press Releases
Ensysce Biosciences Regains Full Compliance with Nasdaq
December 23, 2024
·
3 min read
Deals
Ensysce Biosciences Regains Compliance with Nasdaq
Ensysce Biosciences, Inc. today announced that it has received notice on May 24, 2024 from The Nasdaq Stock Market LLC that the Company has demonstrated compliance with the equity requirement in Listing Rule 5550(b).
May 28, 2024
·
3 min read
Press Releases
Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
January 23, 2025
·
5 min read
Business
Ensysce Biosciences Reports First Quarter 2024 Financial Results
Ensysce Biosciences, Inc. today reported financial and operational results for the first quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Biotech Beach
Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
Ensysce Biosciences, Inc. provides takeaways from Geoff Birkett, the Company’s Chief Commercial Officer, following his participation on the opening panel of the European Pharmaceutical Market Research Association (EPHMRA) Annual Conference in London on June 25.
June 27, 2024
·
5 min read
Biotech Beach
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Ensysce Biosciences, Inc. today announced the achievement of a critical milestone in its opioid use disorder (OUD) program with the selection of a lead drug candidate to move into Investigational New Drug (IND) enabling studies.
June 6, 2024
·
4 min read
1 of 69,861
Next
